Published in J Endourol on December 01, 2002
Laparoscopic partial nephrectomy with diode laser: a promising technique. Photomed Laser Surg (2014) 0.93
Laparoscopic partial nephrectomy: Technical considerations and an update. J Minim Access Surg (2011) 0.80
Laparoscopic Partial Nephrectomy by Diode Laser with Highly Selective Clamping of Segmental Renal Arterial. Chin Med J (Engl) (2015) 0.75
Comparison between a 1.92-μm fiber laser and a standard HF-dissection device for nephron-sparing kidney resection in a porcine in vivo study. Lasers Med Sci (2011) 0.75
BAP1 loss defines a new class of renal cell carcinoma. Nat Genet (2012) 4.97
Best practice policy statement on urologic surgery antimicrobial prophylaxis. J Urol (2008) 4.90
Chapter 1: AUA guideline on management of staghorn calculi: diagnosis and treatment recommendations. J Urol (2005) 4.69
Epidemiology and risk factors of urothelial bladder cancer. Eur Urol (2012) 4.45
Single-incision, umbilical laparoscopic versus conventional laparoscopic nephrectomy: a comparison of perioperative outcomes and short-term measures of convalescence. Eur Urol (2008) 4.09
Systematic review of complications of prostate biopsy. Eur Urol (2013) 3.66
Impact of statin use on oncologic outcomes in patients with urothelial carcinoma of the bladder treated with radical cystectomy. J Urol (2013) 3.35
Ten-Year Outcomes of Renal Tumor Radio Frequency Ablation. J Urol (2019) 3.20
Characteristics and outcomes of patients with clinical T1 grade 3 urothelial carcinoma treated with radical cystectomy: results from an international cohort. Eur Urol (2009) 3.14
Outcomes of radical nephroureterectomy: a series from the Upper Tract Urothelial Carcinoma Collaboration. Cancer (2009) 3.12
Phase I dose-escalation study of stereotactic body radiation therapy for low- and intermediate-risk prostate cancer. J Clin Oncol (2011) 3.12
Recurrence and progression of disease in non-muscle-invasive bladder cancer: from epidemiology to treatment strategy. Eur Urol (2009) 2.99
A gain-of-function mutation in DHT synthesis in castration-resistant prostate cancer. Cell (2013) 2.94
Cost comparison of robotic, laparoscopic, and open radical prostatectomy for prostate cancer. Eur Urol (2009) 2.76
Use of combined apoptosis biomarkers for prediction of bladder cancer recurrence and mortality after radical cystectomy. Lancet Oncol (2007) 2.66
Cost-effectiveness of medical expulsive therapy using alpha-blockers for the treatment of distal ureteral stones. Eur Urol (2007) 2.52
Outcomes of radical cystectomy for transitional cell carcinoma of the bladder: a contemporary series from the Bladder Cancer Research Consortium. J Urol (2006) 2.51
Laparoendoscopic single-site surgery in urology: worldwide multi-institutional analysis of 1076 cases. Eur Urol (2011) 2.46
The impact of tumor multifocality on outcomes in patients treated with radical nephroureterectomy. Eur Urol (2011) 2.43
Patient-reported body image and cosmesis outcomes following kidney surgery: comparison of laparoendoscopic single-site, laparoscopic, and open surgery. Eur Urol (2011) 2.34
Clinical nodal staging scores for bladder cancer: a proposal for preoperative risk assessment. Eur Urol (2011) 2.31
Laparoendoscopic single-site and natural orifice transluminal endoscopic surgery in urology: a critical analysis of the literature. Eur Urol (2010) 2.28
Laboratory and clinical development of single keyhole umbilical nephrectomy. Urology (2007) 2.28
A delay in radical cystectomy of >3 months is not associated with a worse clinical outcome. BJU Int (2007) 2.25
The value of your time: evaluation of effects of changes in medicare reimbursement rates on the practice of urology. J Urol (2004) 2.23
Cost-effectiveness of fluorescence in situ hybridization in patients with atypical cytology for the detection of urothelial carcinoma. J Urol (2013) 2.22
Predictive value of the differential expression of the urokinase plasminogen activation axis in radical prostatectomy patients. Eur Urol (2008) 2.20
Soft tissue surgical margin status is a powerful predictor of outcomes after radical cystectomy: a multicenter study of more than 4,400 patients. J Urol (2010) 2.11
Climate-related increase in the prevalence of urolithiasis in the United States. Proc Natl Acad Sci U S A (2008) 2.09
Renal function outcomes in patients treated for renal masses smaller than 4 cm by ablative and extirpative techniques. J Urol (2007) 2.07
Phase one pilot study using magnetic resonance spectroscopy to predict the histology of radiofrequency-ablated renal tissue. Eur Urol (2008) 2.03
Effect of ascorbic acid consumption on urinary stone risk factors. J Urol (2003) 2.02
The new economics of radical prostatectomy: cost comparison of open, laparoscopic and robot assisted techniques. J Urol (2004) 1.97
Perioperative outcomes in patients undergoing conventional laparoscopic versus laparoendoscopic single-site pyeloplasty. Urology (2009) 1.96
Advanced age is associated with poorer bladder cancer-specific survival in patients treated with radical cystectomy. Eur Urol (2006) 1.86
Assessment of basic endoscopic performance using a virtual reality simulator. J Am Coll Surg (2002) 1.86
Nomograms provide improved accuracy for predicting survival after radical cystectomy. Clin Cancer Res (2006) 1.84
A validated tumorgraft model reveals activity of dovitinib against renal cell carcinoma. Sci Transl Med (2012) 1.84
Cost comparison of robotic, laparoscopic, and open partial nephrectomy. J Endourol (2011) 1.83
Association of angiogenesis related markers with bladder cancer outcomes and other molecular markers. J Urol (2010) 1.83
Discrepancy between clinical and pathologic stage: impact on prognosis after radical cystectomy. Eur Urol (2006) 1.82
Endoscopically guided percutaneous renal access: "seeing is believing". J Endourol (2006) 1.81
Cost-effectiveness of medical management strategies for nephrolithiasis. J Urol (2004) 1.81
Radiofrequency ablation versus partial nephrectomy in patients with solitary clinical T1a renal cell carcinoma: comparable oncologic outcomes at a minimum of 5 years of follow-up. Eur Urol (2012) 1.78
Urinary cytology has a poor performance for predicting invasive or high-grade upper-tract urothelial carcinoma. BJU Int (2011) 1.78
Stage-specific impact of tumor location on oncologic outcomes in patients with upper and lower tract urothelial carcinoma following radical surgery. Eur Urol (2012) 1.65
Are patients with hematuria appropriately referred to Urology? A multi-institutional questionnaire based survey. Urol Oncol (2008) 1.64
Current status and future directions of robotic single-site surgery: a systematic review. Eur Urol (2012) 1.63
Single-incision laparoscopic surgery: initial urological experience and comparison with natural-orifice transluminal endoscopic surgery. BJU Int (2008) 1.62
Laparoendoscopic single-site surgery in urology: where have we been and where are we heading? Nat Clin Pract Urol (2008) 1.62
The contemporary management of renal and ureteric calculi. BJU Int (2006) 1.62
Lymphadenectomy at the time of nephroureterectomy for upper tract urothelial cancer. Eur Urol (2011) 1.62
Effect of dietary modification on urinary stone risk factors. Kidney Int (2005) 1.61
Human epidermal growth factor receptor 2 expression status provides independent prognostic information in patients with urothelial carcinoma of the urinary bladder. BJU Int (2010) 1.61
Completely transvaginal NOTES cholecystectomy using magnetically anchored instruments. Surg Endosc (2007) 1.61
Characteristics and outcomes of patients with pT4 urothelial carcinoma at radical cystectomy: a retrospective international study of 583 patients. J Urol (2010) 1.61
Cost-effectiveness of standard vs intensive antibiotic regimens for transrectal ultrasonography (TRUS)-guided prostate biopsy prophylaxis. BJU Int (2011) 1.60
Three differentiation states risk-stratify bladder cancer into distinct subtypes. Proc Natl Acad Sci U S A (2012) 1.60
Conservative management in selected patients with upper tract urothelial carcinoma compares favourably with early radical surgery. BJU Int (2008) 1.60
Clinical outcomes following radical cystectomy for primary nontransitional cell carcinoma of the bladder compared to transitional cell carcinoma of the bladder. J Urol (2006) 1.60
Risk stratification of organ confined bladder cancer after radical cystectomy using cell cycle related biomarkers. J Urol (2011) 1.59
Durable oncologic outcomes after radiofrequency ablation: experience from treating 243 small renal masses over 7.5 years. Cancer (2010) 1.58
Long-term outcomes in healthy adults after radiofrequency ablation of T1a renal tumours. BJU Int (2013) 1.58
Validation of the AJCC TNM substaging of pT2 bladder cancer: deep muscle invasion is associated with significantly worse outcome. Eur Urol (2010) 1.57
Management of ureteral calculi: a cost comparison and decision making analysis. J Urol (2002) 1.57
Impact of smoking on oncologic outcomes of upper tract urothelial carcinoma after radical nephroureterectomy. Eur Urol (2012) 1.57
Trocar-less instrumentation for laparoscopy: magnetic positioning of intra-abdominal camera and retractor. Ann Surg (2007) 1.57
Lymphovascular invasion predicts clinical outcomes in patients with node-negative upper tract urothelial carcinoma. J Clin Oncol (2008) 1.54
Implications of the prostate cancer prevention trial: a decision analysis model of survival outcomes. J Clin Oncol (2005) 1.54
Minimally invasive nephrectomy: the influence of laparoendoscopic single-site surgery on patient selection, outcomes, and morbidity. Urology (2010) 1.54
Radiation exposure in the acute and short-term management of urolithiasis at 2 academic centers. J Urol (2008) 1.53
Prognostic role of cell cycle and proliferative biomarkers in patients with clear cell renal cell carcinoma. J Urol (2013) 1.53
Association of diabetes mellitus and metformin use with oncological outcomes of patients with non-muscle-invasive bladder cancer. BJU Int (2013) 1.53
The impact of previous ureteroscopic tumor ablation on oncologic outcomes after radical nephrouretectomy for upper urinary tract urothelial carcinoma. J Endourol (2011) 1.53
Contemporary use of perioperative cisplatin-based chemotherapy in patients with muscle-invasive bladder cancer. Cancer (2010) 1.53
Impact of lymph node dissection on cancer specific survival in patients with upper tract urothelial carcinoma treated with radical nephroureterectomy. J Urol (2009) 1.52
Expression of cyclooxygenase-2 in normal urothelium, and superficial and advanced transitional cell carcinoma of bladder. J Urol (2007) 1.52
Upper urinary tract urothelial carcinoma with loco-regional nodal metastases: insights from the Upper Tract Urothelial Carcinoma Collaboration. BJU Int (2011) 1.50
Urological laparoendoscopic single site surgery: multi-institutional analysis of risk factors for conversion and postoperative complications. J Urol (2012) 1.50
Outcomes of patients with clinical T1 grade 3 urothelial cell bladder carcinoma treated with radical cystectomy. Urology (2008) 1.50
Prognostic value of syndecan-1 expression in patients treated with radical prostatectomy. BJU Int (2007) 1.50
ICUD-EAU International Consultation on Bladder Cancer 2012: Screening, diagnosis, and molecular markers. Eur Urol (2012) 1.49
Impact of peri-operative blood transfusion on the outcomes of patients undergoing radical cystectomy for urothelial carcinoma of the bladder. BJU Int (2014) 1.49
Consensus statement on natural orifice transluminal endoscopic surgery and single-incision laparoscopic surgery: heralding a new era in urology? Eur Urol (2008) 1.48
Prospective evaluation of a preoperative biomarker panel for prediction of upstaging at radical cystectomy. BJU Int (2014) 1.48
Training on a virtual reality laparoscopic simulator improves performance of an unfamiliar live laparoscopic procedure. J Urol (2008) 1.48
Laparoscopic radical nephrectomy: oncologic efficacy. Urol Clin North Am (2003) 1.47
Sirolimus in metatastic renal cell carcinoma. J Clin Oncol (2008) 1.47
Obesity is associated with worse oncological outcomes in patients treated with radical cystectomy. BJU Int (2012) 1.46
Potential cost-effectiveness of therapeutic drug monitoring in patients with resistant hypertension. J Hypertens (2014) 1.46
Laparoscopic partial nephrectomy using holmium laser in a porcine model. JSLS (2004) 1.46